Literature DB >> 3414490

Noninvasive quantification of mitral regurgitation in dilated cardiomyopathy: correlation of two Doppler echocardiographic methods.

G Keren1, S Katz, J Strom, E H Sonnenblick, T H LeJemtel.   

Abstract

The presence and severity of functional mitral regurgitation were quantified by Doppler echocardiography in 17 patients with dilated cardiomyopathy and no evidence of primary valvular disease. Mitral regurgitant fraction was greater than 20% in 11 of the 17 patients, and exceeded 40% in four patients. Total stroke volume, calculated from the difference between end-diastolic and end-systolic volumes obtained by two-dimensional echocardiography, correlated well with mitral valve inflow determined by Doppler echocardiography (r = 0.90, p less than 0.001). Similarly, mitral regurgitant volume, calculated as the difference between echocardiographic total stroke volume and forward aortic volume obtained by Doppler echocardiography, correlated well with regurgitant volume calculated as the difference between mitral valve inflow and forward aortic flow, both determined by Doppler echocardiography (r = 0.90, p less than 0.001). Accordingly, functional mitral regurgitation can be conveniently demonstrated in patients with dilated cardiomyopathy by two different Doppler echocardiography methods, whose results are closely correlated. Mitral regurgitant fraction is greater than 20% in two thirds of the patients with a dilated cardiomyopathy.

Entities:  

Mesh:

Year:  1988        PMID: 3414490     DOI: 10.1016/0002-8703(88)90334-1

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  2 in total

Review 1.  Quantitative assessment of mitral insufficiency: its advantages and disadvantages.

Authors:  Anna Paszczuk; Susan E Wiegers
Journal:  Heart Fail Rev       Date:  2006-09       Impact factor: 4.214

2.  Effect of left bundle branch block on diastolic function in dilated cardiomyopathy.

Authors:  H B Xiao; C H Lee; D G Gibson
Journal:  Br Heart J       Date:  1991-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.